Abstract
Epstein-Barr virus (EBV) infection rate is very high in populations. It has been found that EBV is associated with many human diseases including an obviously heterogeneous group of cutaneous lymphomas, such as extranodal natural killer (NK) /T-cell lymphoma, hydroa vacciniforme-like lymphoma, Hodgkin′s lymphoma, Burkitt′s lymphoma, HIV-associated lymphoma and so on. EBV-associated cutaneous lymphomas have various clinical manifestations, a spectrum of histological changes with chronic or critical disease course and poor prognosis. Mechanisms of EBV-mediated oncogenesis are still unclear. By the interaction between functional molecules of EBV and the host, EBV can escape from cellular immunity in host, modulate multiple signaling pathways, promote tumor inflammation, induce blood vessel formation and gene mutations, and finally immortalize host cells. In clinic, high-risk population should be tracked and monitored, such as undernourished and immunocompromised persons, especially children, the elderly, organ transplant patients, and HIV-infected individuals, so as to early diagnose and interfere in EBV-associated cutaneous lymphomas. Key words: Herpesvirus 4, human; Skin; Lymphoma; Methods; Diagnosis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Dermatology and Venereology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
